Itzcovich Tatiana, Xi Zhengrui, Martinetto Horacio, Chrem-Méndez Patricio, Russo María Julieta, de Ambrosi Bruno, Uchitel Osvaldo D, Nogués Martín, Silva Emanuel, Rojas Galeno, Bagnatti Pablo, Amengual Alejandra, Campos Jorge, Rogaeva Ekaterina, St George-Hyslop Peter, Allegri Ricardo, Sevlever Gustavo, Surace Ezequiel I
Laboratorio de Biología Molecular, Departamento de Neuropatología, Instituto de Investigaciones Neurológicas Dr. Raúl Carrea (FLENI), Buenos Aires, Argentina.
Tanz Centre for Research in Neurodegenerative Diseases, University of Toronto, Toronto, Ontario, Canada.
Neurobiol Aging. 2016 Apr;40:192.e13-192.e15. doi: 10.1016/j.neurobiolaging.2016.02.001. Epub 2016 Feb 6.
Pathologic expansion of the G4C2 repeat in C9orf72 is the main genetic cause of frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS). To evaluate the frequency of the G4C2 expansion in a Latin American cohort of FTD and ALS patients, we used a 2-step genotyping strategy. For FTD, we observed an overall expansion frequency of 18.2% (6 of 33 unrelated cases). Moreover, the C9orf72 expansion accounted for 37.5% of all familial FTD cases (6 of 16 families). The expansion frequency in sporadic ALS cases was 2% (1 of 47 unrelated patients), whereas we observed the expansion in 1 of 3 families with a positive history for ALS. Overall, the expansion frequency in our FTD group was similar to that reported for patients in Europe and North America, whereas the frequency in our sporadic ALS group was significantly lower. To our knowledge, this is the first report on the frequency of the C9orf72 expansion in a Latin American population.
C9orf72基因中G4C2重复序列的病理性扩增是额颞叶痴呆(FTD)和肌萎缩侧索硬化症(ALS)的主要遗传病因。为评估拉丁美洲FTD和ALS患者队列中G4C2扩增的频率,我们采用了两步基因分型策略。对于FTD,我们观察到总体扩增频率为18.2%(33例无亲缘关系病例中的6例)。此外,C9orf72扩增占所有家族性FTD病例的37.5%(16个家族中的6个)。散发性ALS病例的扩增频率为2%(47例无亲缘关系患者中的1例),而在有ALS阳性家族史的3个家族中,我们观察到1个家族存在扩增。总体而言,我们FTD组的扩增频率与欧洲和北美患者的报道相似,而我们散发性ALS组的频率显著较低。据我们所知,这是关于拉丁美洲人群中C9orf72扩增频率的首次报告。